Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:11 pm Sale | 2022-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Cormorant Asset Management, LP | 2,893,717 5.980% | -108,483 (-3.61%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | T. Rowe Price Associates, Inc. | 3,683,430 7.600% | -1,175,197 (-24.19%) | Filing History |
| 2023-02-14 09:40 am Purchase | 2022-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Avoro Capital Advisors LLC | 4,325,000 8.900% | 1,013,566 (+30.61%) | Filing History |
| 2023-02-09 12:01 pm Sale | 2023-02-09 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | FMR LLC | 6,217,458 12.846% | -758,429 (-10.87%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BlackRock, Inc. BLK | 3,598,536 7.400% | 2,006,738 (+126.07%) | Filing History |
| 2022-02-14 3:08 pm Sale | 2021-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Cormorant Asset Management, LP | 3,002,200 6.460% | -191,774 (-6.00%) | Filing History |
| 2022-02-11 10:06 am Purchase | 2021-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Avoro Capital Advisors LLC | 3,311,434 7.100% | 3,311,434 (New Position) | Filing History |
| 2022-02-10 1:16 pm Purchase | 2022-01-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | T. Rowe Price Associates, Inc. | 4,858,627 10.400% | 711,708 (+17.16%) | Filing History |
| 2022-02-10 1:13 pm Purchase | 2021-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | T. Rowe Price Associates, Inc. | 4,146,919 8.900% | 4,146,919 (New Position) | Filing History |
| 2022-02-09 5:22 pm Sale | 2022-01-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BlackRock, Inc. BLK | 1,591,798 3.400% | -761,966 (-32.37%) | Filing History |
| 2022-02-09 09:22 am Purchase | 2022-02-08 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | FMR LLC | 6,975,887 14.999% | 803,610 (+13.02%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BlackRock, Inc. BLK | 2,353,764 5.100% | 2,353,764 (New Position) | Filing History |
| 2021-08-10 10:33 am Purchase | 2021-08-09 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | FMR LLC | 6,172,277 13.873% | 6,172,277 (New Position) | Filing History |